195 related articles for article (PubMed ID: 36435613)
1. Breast Cancer Pathology in the Era of Genomics.
Wen HY; Collins LC
Hematol Oncol Clin North Am; 2023 Feb; 37(1):33-50. PubMed ID: 36435613
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer in the era of precision medicine.
Sarhangi N; Hajjari S; Heydari SF; Ganjizadeh M; Rouhollah F; Hasanzad M
Mol Biol Rep; 2022 Oct; 49(10):10023-10037. PubMed ID: 35733061
[TBL] [Abstract][Full Text] [Related]
3. Genomic Pathology and Biomarkers in Breast Cancer.
Zhang Z; Tang P
Crit Rev Oncog; 2017; 22(5-6):411-426. PubMed ID: 29604921
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
Zivanovic Bujak A; Weng CF; Silva MJ; Yeung M; Lo L; Ftouni S; Litchfield C; Ko YA; Kuykhoven K; Van Geelen C; Chandrashekar S; Dawson MA; Loi S; Wong SQ; Dawson SJ
PLoS Med; 2020 Oct; 17(10):e1003363. PubMed ID: 33001984
[TBL] [Abstract][Full Text] [Related]
5. The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine.
Masood S
Breast J; 2020 Jan; 26(1):27-34. PubMed ID: 31876097
[TBL] [Abstract][Full Text] [Related]
6. Changing Landscape of Clinical-Genomic Oncology Practice.
Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
van Geelen CT; Savas P; Teo ZL; Luen SJ; Weng CF; Ko YA; Kuykhoven KS; Caramia F; Salgado R; Francis PA; Dawson SJ; Fox SB; Fellowes A; Loi S
Breast Cancer Res; 2020 Aug; 22(1):91. PubMed ID: 32811538
[TBL] [Abstract][Full Text] [Related]
8. Current concepts in breast cancer genomics: An evidence based review by the CGC breast cancer working group.
Geiersbach KB; Chen H; Emmadi R; Haskell GT; Lu X; Liu YJ; Swisshelm K
Cancer Genet; 2020 Jun; 244():11-20. PubMed ID: 32087595
[TBL] [Abstract][Full Text] [Related]
9. Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward "precision" cancer therapy.
Turner BM; Hicks DG
Biotech Histochem; 2017; 92(3):175-200. PubMed ID: 28318327
[TBL] [Abstract][Full Text] [Related]
10. Precision Medicine in Breast Cancer.
Odle TG
Radiol Technol; 2017 Mar; 88(4):401M-421M. PubMed ID: 28298516
[TBL] [Abstract][Full Text] [Related]
11. New Advances in Molecular Breast Cancer Pathology.
Rakha EA; Pareja FG
Semin Cancer Biol; 2021 Jul; 72():102-113. PubMed ID: 32259641
[TBL] [Abstract][Full Text] [Related]
12. Standard and Genomic Tools for Decision Support in Breast Cancer Treatment.
Henry NL; Bedard PL; DeMichele A
Am Soc Clin Oncol Educ Book; 2017; 37():106-115. PubMed ID: 28561710
[TBL] [Abstract][Full Text] [Related]
13. Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood.
Miller E; Schwartzberg L
Curr Treat Options Oncol; 2020 Sep; 21(11):89. PubMed ID: 32875404
[TBL] [Abstract][Full Text] [Related]
14. Mutation matters in precision medicine: A future to believe in.
Dey N; Williams C; Leyland-Jones B; De P
Cancer Treat Rev; 2017 Apr; 55():136-149. PubMed ID: 28371665
[TBL] [Abstract][Full Text] [Related]
15. Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
Fumagalli C; Ranghiero A; Gandini S; Corso F; Taormina S; De Camilli E; Rappa A; Vacirca D; Viale G; Guerini-Rocco E; Barberis M
Breast Cancer Res; 2020 Oct; 22(1):107. PubMed ID: 33059724
[TBL] [Abstract][Full Text] [Related]
16. Genetics and Genomics of Breast Cancer: update and translational perspectives.
Biancolella M; Testa B; Baghernajad Salehi L; D'Apice MR; Novelli G
Semin Cancer Biol; 2021 Jul; 72():27-35. PubMed ID: 32259642
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX
Curtit E; Mansi L; Maisonnette-Escot Y; Sautière JL; Pivot X
Eur J Surg Oncol; 2017 May; 43(5):921-930. PubMed ID: 28087099
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive parameters in breast pathology: a pathologist's primer.
Allison KH
Mod Pathol; 2021 Jan; 34(Suppl 1):94-106. PubMed ID: 33154551
[TBL] [Abstract][Full Text] [Related]
19. Precision diagnostics: integration of tissue pathology and genomics in cancer.
Sharma S; George P; Waddell N
Pathology; 2021 Dec; 53(7):809-817. PubMed ID: 34635323
[TBL] [Abstract][Full Text] [Related]
20. Initial experience with genomic profiling of heavily pretreated breast cancers.
Staren ED; Braun D; Tan B; Gupta D; Kim S; Kramer K; Markman M
Ann Surg Oncol; 2014 Oct; 21(10):3216-22. PubMed ID: 25047475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
